CompuGroup Medical SE, DE0005437305

CompuGroup Medical SE, DE0005437305

11.02.2019 - 10:50:34

CompuGroup Medical SE: Release of a capital market information

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 8th Interim Announcement

CompuGroup Medical SE / Share Buyback

Koblenz, February 11 2019

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 8th Interim Announcement

In the period from February 4, 2019, up to and including February 8, 2019, CompuGroup Medical SE has bought back a total of 35,417 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of December 14, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on December 17, 2018.

The overall volume of the shares bought back daily in the period from February 4, 2019, up to and including February 8, 2019, and the daily volume-weighted average stock market prices of the shares are as follows:

Date Overall volume of Volume-weighted average shares bought back stock market price (number) (EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice) February 4, 2019 2,534 47.5930 February 5, 2019 7,021 48.2803 February 6, 2019 6,400 48.7610 February 7, 2019 10,812 48.8011 February 8, 2019 8,650 48.6587 In total: 35,417 48,5694

The total number of shares which have been bought back so far by CompuGroup Medical SE since December 17, 2018, up to and including February 8, 2019, within the framework of the share buyback program thus amounts to 223,989 no-par value shares.

Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb.

The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading).

Koblenz, February 11, 2019

The Management Board

CompuGroup Medical SE Investor Relations Maria Trost 21 56070 Koblenz, Germany T: 49 (0) 261 8000-6200 F: 49 (0) 261 8000-3200

11.02.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz

Germany Internet: www.cgm.com   End of News DGAP News Service

774301  11.02.2019 

@ dgap.de